DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Abergel A, Hezode C, Asselah T. et al.
High Efficacy and Safety of the Combination HCV Regimen Elbasvir and Grazoprevir for 8 Weeks in Treatment-Naive, Non-Severe Fibrosis HCV GT1b-Infected Patients: Final Results of the Streager Study.
Hepatology 2018;
68: 1453a-1454a
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.